tiprankstipranks
Trending News
More News >
Incyte (INCY)
:INCY
US Market
Advertisement

Incyte (INCY) Earnings Dates, Call Summary & Reports

Compare
1,787 Followers

Earnings Data

Report Date
Feb 18, 2026
Before Open (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
1.89
Last Year’s EPS
1.43
Same Quarter Last Year
Moderate Buy
Based on 18 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Oct 28, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call highlighted strong financial performance and growth in key products like Jakafi and Opzelura. The launch of Niktimvo exceeded expectations. However, the decision to terminate certain programs due to regulatory and strategic priorities presented challenges. Overall, the sentiment was more positive given the revenue growth and successful product launches.
Company Guidance
Incyte's third-quarter 2025 earnings call revealed a robust financial performance and optimistic guidance for the future. Total revenues reached $1.37 billion, with product sales at $1.15 billion, marking a 20% and 19% increase, respectively, from the previous year. Jakafi achieved Q3 sales of $791 million, with a 7% increase driven by a 10% year-over-year demand growth. The company raised its full-year guidance for Jakafi to a range of $3.05 billion to $3.075 billion. Opzelura also showed strong growth, recording $188 million in sales, a 35% year-over-year increase, with international sales for vitiligo growing by 117%. Niktimvo continued to outperform expectations, with Q3 sales totaling $46 million, a 27% increase from the previous quarter. The company plans to focus on strategic investments in high-value R&D projects and anticipates the initiation of pivotal trials for key pipeline products, aiming to drive future growth and maintain financial discipline.
Strong Revenue Growth
Total revenues of $1.37 billion and product sales of $1.15 billion, representing a 20% and 19% increase, respectively, versus prior year.
Jakafi Performance
Jakafi Q3 sales reached $791 million, a 7% increase with strong demand growth of 10% year-over-year.
Opzelura Sales Surge
Opzelura sales reached $188 million, a 35% increase versus prior year. Sales in the U.S. were $144 million, a 21% increase.
Niktimvo Launch Success
Niktimvo sales in the third quarter totaled $46 million, an increase of 27% versus the second quarter.
Pipeline and R&D Focus
Strategic focus on high-value programs and key updates in solid tumor and povorcitinib programs.

Incyte (INCY) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

INCY Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 18, 2026
2025 (Q4)
1.89 / -
1.426
Oct 28, 2025
2025 (Q3)
1.61 / 2.26
1.07111.21% (+1.19)
Jul 29, 2025
2025 (Q2)
1.42 / 1.57
-1.818186.47% (+3.39)
Apr 29, 2025
2025 (Q1)
0.99 / 1.16
0.64380.40% (+0.52)
Feb 10, 2025
2024 (Q4)
1.50 / 1.43
1.05834.78% (+0.37)
Oct 29, 2024
2024 (Q3)
1.05 / 1.07
1.1-2.73% (-0.03)
Jul 30, 2024
2024 (Q2)
0.75 / -1.82
0.9-302.00% (-2.72)
Apr 30, 2024
2024 (Q1)
0.78 / 0.64
0.1543.00% (+0.54)
Feb 13, 2024
2023 (Q4)
1.15 / 1.06
0.13713.85% (+0.93)
Oct 31, 2023
2023 (Q3)
0.83 / 1.10
0.5120.00% (+0.60)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

INCY Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Oct 28, 2025
$93.08$91.65-1.54%
Jul 29, 2025
$70.16$77.38+10.29%
Apr 29, 2025
$59.52$60.43+1.53%
Feb 10, 2025
$74.13$68.30-7.86%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Incyte (INCY) report earnings?
Incyte (INCY) is schdueled to report earning on Feb 18, 2026, Before Open (Confirmed).
    What is Incyte (INCY) earnings time?
    Incyte (INCY) earnings time is at Feb 18, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is INCY EPS forecast?
          INCY EPS forecast for the fiscal quarter 2025 (Q4) is 1.89.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis